Johnson & Johnson at Barclays Global Healthcare Conference Transcript
All right. It's still morning, so good morning, everybody. Very happy to have with us this year from J&J, Hani Abouhalka, Group Chairman of Surgery, otherwise known as the man behind the robot. And my name is Matt Miksic. I cover MedTech here at Barclays, so exciting times at Johnson & Johnson and Surgery.
Questions & Answers
After a bunch of years, we won't go backwards, we'll go forwards, but a long path with lots of twists and turns, but now kind of a final stretch of potentially getting this robot to market. So maybe with that kind of perspective, we get a lot of questions sometimes on why does J&J want to have a robot, why do they need to have a robot, what can the robot add?
I know that not everything you put together was in response to the marketplace, but at a high level, maybe frame the objectives of the project and the strategy behind the project as you're currently executing it.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

